Amicus Therapeutics [FOLD] vs Cg Oncology [CGON] Detailed Comparison

TLDR: Quick Comparison Summary

Based on 12 vital metrics comparison: Amicus Therapeutics wins in 4 metrics, Cg Oncology wins in 7 metrics, with 1 ties. Cg Oncology appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Amicus Therapeutics Cg Oncology Better
P/E Ratio (TTM) -34.78 -18.60 Amicus Therapeutics
Price-to-Book Ratio 9.94 2.84 Cg Oncology
Debt-to-Equity Ratio 229.11 0.15 Cg Oncology
PEG Ratio 39.09 -14.73 Cg Oncology
EV/EBITDA 38.29 -9.95 Cg Oncology
Profit Margin -5.41% 0.00% Cg Oncology
Operating Margin -6.35% -81,161.54% Amicus Therapeutics
Return on Equity -18.12% -16.58% Cg Oncology
Return on Assets 3.95% -12.85% Amicus Therapeutics
Free Cash Flow $-37.44M $-78.95M Amicus Therapeutics
Dividend Yield 0.00% 0.00% Tie
1-Year Return -35.61% -22.53% Cg Oncology
Overview
Performance
Valuation
Financials
Short Interest
Dividends

Amicus Therapeutics vs Cg Oncology Price History Comparison

Key Statistics Comparison

Loading Statistics...

Performance

Amicus Therapeutics vs Cg Oncology Performance Comparison Chart

Loading Price Chart...

Performance Comparison

Loading Performance Data...

Valuation

Valuation History

Loading Valuation History...

Market Capitalization % Change

P/E Ratio (TTM)

Forward P/E

PEG Ratio

Price to Sales (TTM)

Price to Book (MRQ)

Enterprise Value % Change

EV/EBITDA

EV/Revenue

Valuation Metrics

Loading Valuation Metrics...

Financials

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement Comparison (TTM)

Loading Financials...

Short Interest And Ownership

Short Interest And Ownership Metrics

Loading Short Interest And Ownership Data...

Dividends

Dividend Information

Loading Dividend Information...